Accès ouvert
2026
article
OpenAlex
Xiaolu Tang, Rui Chen, Jiawei Xing, Qing Huang et autres
BACKGROUND: Current therapies for Alzheimer's disease (AD) offer only symptomatic relief, highlighting the urgent need for disease-modifying approaches capable of halting or reversing neurodegeneration. Extracellular vesicles (EVs) have attracted growing interest as therapeutic vehicles owing to their inherent capacity to bypass the …
cn, mo
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Changjun Su, Jiucheng Shen, Kaida Guo, Jing Wang et autres
INTRODUCTION: Solriamfetol, a dopamine and norepinephrine reuptake inhibitor, is indicated for the treatment of excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA). This study aims to evaluate the efficacy and safety profiles of solriamfetol across different severity levels of OSA …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Mengleang Rek, Nabila Ibn Ziyat, Rui Chen, Xixing Xu et autres
BACKGROUND: Undernutrition among children under five years (CUFY) is a leading global public health issue worldwide, including in Cambodia. This study aimed to determine the prevalence of undernutrition and the mediating effect of maternal depression and household food insecurity on the association …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jing Wang, Tianying Chang, Yiqiang Wang, Jinling Zhang et autres
BACKGROUND: Currently, observational studies and clinical trials have shown that the occurrence of coronary heart disease (CHD) is closely related to anti-Helicobacter pylori (H. pylori) IgG seropositivity, but these studies may be affected by confounding factors, resulting in a causal relationship that …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Xiaotian Zhang, Dong Zhang, Qichang Liu, Zhipeng Cao et autres
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ting Zhu, Rui Chen, Haoyang Kang, F. Ding et autres
BACKGROUND: Chronic lateral ankle instability (CLAI) is frequently complicated by osteochondral lesion of the talus (OLT), which accelerate cartilage degeneration due to abnormal stress concentration and may progress to ankle osteoarthritis. However, in vivo biomechanical alterations in patients with concurrent CLAI and …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Gang Li, Rui Chen, Xinran Wang, Hao Zhang et autres
Esophageal squamous cell carcinoma (ESCC) is an aggressive malignancy with limited therapies and poor prognosis. While exhausted T cell (Tex) heterogeneity under chronic antigen stimulation is recognized, the role of Tex subsets in shaping the tumor microenvironment (TME) and influencing ESCC outcomes …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Peipei Yang, Rui Chen, Huijuan He
Lung cancer (LC) is consistently the leading cause of cancer-related deaths worldwide. Radiotherapy is a crucial means of treating LC, and about 60-70% of LC patients require radiotherapy. However, radiotherapy resistance remains a significant challenge for treatment outcomes. Non-coding RNAs (ncRNAs) are …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Tianyi Wu, Yun Teng, Hao Yu, Junjie Niu et autres
cn
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Xiaohong Han, Rui Chen
Introduction: Transthyretin amyloidosis (ATTR) is a progressive disease characterized by abnormal buildup amyloid of misfolded transthyretin (TTR) protein in multiple organs and the major disease manifestations include polyneuropathy and cardiomyopathy. The pathogenic amyloid accumulation results in organ dysfunction and reduced life expectancy. …
cn
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Lu Zhang, Rui Chen, Yujun Dong, Q. Wang et autres
Abstract Interleukin-6 (IL-6) targeted therapy has been recommended as the most important treatment option for idiopathic Multicentric Castleman Disease (iMCD). Although siltuximab has been approved in many countries, this first IL-6 blocking antibody only revealed a beneficial effect for 34% of patients …
cn
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Sarah A. Johnson, Rui Chen, Qian Zhao, Cuifang Hao et autres
Background JL18008 is a genetically engineered fusion protein of human serum albumin (HSA) and IL-7 designed for clinical use with an enhanced half-life. The preclinical data showed that JL18008 recovered T cell counts in lymphocytopenic animal models. This study is a first-in-human, …
cn
(code pays fourni par la source)